Download
Kratom References
PDF
8-Factor Analysis and Recommendations by Pinney Associates (2016).pdf
PDF
A Botanical, Phytochemical and Ethnomedicinal Review of the Genus Mitragyna korth: Implications for Products Sold as Kratom (2017).pdf
PDF
A New Indole Alkaloid, 7aHydroxy- 7H-mitragynine, from Mitragyna speciosa in Thailand (1994).pdf
PDF
A Review on Herbal Plants Showing Antidepressant Activity (2011).pdf
PDF
ABC - DEA (Comments - Docket No. DEA-442W).pdf
PDF
Abuse Liability and Therapeutic Potential of the Mitragyna speciosa (Kratom) Alkaloids Mitragynine and 7-hydroxymitragynine (2018).pdf
PDF
Abuse Liability of Mitragynine Assessed with a Self-Administration Procedure in Rats (2018).pdf
PDF
ACS: 7-Hydroxymitragynine is an Active Metabolite of Mitragynine and a Key Mediator of its Analgesic Effects - Supporting Information (2019).pdf
PDF
ACS: 7-Hydroxymitragynine is an Active Metabolite of Mitragynine and a Key Mediator of Its Analgesic Effects (2019).pdf
PDF
Active Metabolite of Mitragynine and a Key Mediator of its Analgesic Effects (2019).pdf
PDF
Acute Toxicity Study of Standardized Mitragyna speciosa Korth (2012).pdf
PDF
Addiction: Self-Treatment of Opioid Withdrawal Using Kratom (2008).pdf
PDF
AHPA - DEA (Comments - Docket No. DEA-442W).pdf
PDF
AHPA - Letter to DEA: Emergency Listing - Temporary Placement (FINAL) 9-30-16.pdf
PDF
AKA - CDC Report on Salmonella Infections Linked to Kratom (2018).pdf
PDF
AKA - Chairman Goodlatte Letter (2017).pdf
PDF
AKA - DEA: Kratom (Mitragyna speciosa) Synopsis.docx.pdf
PDF
AKA - Hogan Lovells - SITSA Memorandum (2017).pdf
PDF
AKA - Information Packet (2017).pdf
PDF
AKA - Kratom 'By the Numbers' Infographic (2017).pdf
PDF
AKA - Petition to Review and Correct the FDA's Public Health Advisory on Kratom (2017).pdf
PDF
AKA - State of Rhode Island - Department of Health (2017).pdf
PDF
AKA - Statement of Principles on Regulating Kratom (2017).pdf
PDF
AKA - Testimonies of Kratom Consumers - Hogan Lovells Attachment (2016).pdf
PDF
AKA - The Human and Economic Impacts of the Kratom Industry in the United States (2017).pdf
PDF
AKA: FDA Kratom Death Data - Exaggerated Claims, Discredited Research, and Distorted Data Fail to Meet the Evidentiary Standard for Placing Kratom as a Schedule I Controlled Substance (2018).pdf
PDF
American Pain Society (Definitions).pdf
PDF
American Society for Pharmacology and Experimental Therapeutics on Kratom Scheduling (2018).pdf
PDF
An Accidental Poisoning with Mitragynine (2014).pdf
PDF
An Analytical Study: Mitragyna speciosa - Jace A. Daniels (2015).pdf
PDF
An Evidence Based Systematic Review of Kratom (2013).pdf
PDF
An Examination of the Consequences of Chronic Exposure to Mitragyna speciosa During Adolescence on Learning and Memory in Adulthood (2014).pdf
PDF
An Optimised Recovery of Mitragynine from Mitragyna speciosa Using Freeze Drying and Ultra-Sonic Assisted Extraction Method (2013).pdf
PDF
Analysis of Mitragynine and Other Alkaloids in Mitragyna speciosa Plants (2014).pdf
PDF
Analysis of Two Deaths Reportedly Associated with Kratom Use (Dr. Jane Babin).pdf
PDF
Anti-Inflammatory and Antinociceptive Effects of Mitragyna speciosa Korth Methanolic Extract (2009).pdf
PDF
Antidepressant-like Effect of Mitragynine Isolated from Mitragyna speciosa Korth in Mice Model of Depression (2011).PDF
PDF
Antinociceptive Effect of 7-hydroxymitragynine in Mice- Discovery of an Orally active opioid analgesic from the Thai Medicinal Herb Mitragyna speciosa (2003).pdf
PDF
Antioxidant and α-glucosidase Inhibitory Activities of the Leaf and Stem of Selected Traditional Medicinal Plants (2014).pdf
PDF
Antioxidant Value and Antiproliferative Efficacy of Mitragynine and a Silane Reduced Analogue (2014).pdf
PDF
Anxiolytic-like Effects of Mitragynine in the Open-Field and Elevated Plus-Maze Tests in Rats (2014).pdf
PDF
ASBMB - The Science Behind Kratom's Strange Leaves (2017).pdf
PDF
Assessment of Gonadotropins and Testosterone Hormone Levels in Regular Mitragyna speciosa (Korth.) Users(2018).pdf
PDF
BEA - A Product of Use, Not a Product of Abuse (Pamphlet).pdf
PDF
BEA - Banning Kratom is Not the Answer (Ryan F. Estevez, MD, PhD, MPH).pdf
PDF
BEA (Call-To-Action/Format Letter).pdf
PDF
Behavioral and Neurochemical Characterization of Kratom Extract (2014).pdf
PDF
Behavioural and Electrophysiological Evidence of Impaired Learning and Memory in Male Sprague Dawley Rats following Subchronic Exposure to Standardised Methanolic Extract of Mitragyna Speciosa (2015).pdf
PDF
Biak (Kratom): An Opium Substitute - Journal of the Federated Malay States Museums (1907).pdf